A Study of Xeloda (Capecitabine) in Breast Cancer Patients With Central Nervous System (CNS) Progression
Clinical trial NCT01077726 · COMPLETED
Trial details
- NCT number
- NCT01077726
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-01-01
- Primary completion
- 2010-12-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.